Comparative Pharmacology
Head-to-head clinical analysis: GENERLAC versus MIRALAX.
Peer-Reviewed Evidence
Head-to-head clinical analysis: GENERLAC versus MIRALAX.
GENERLAC vs MIRALAX
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Lactulose is a synthetic disaccharide that is not absorbed in the small intestine. It is metabolized by colonic bacteria to short-chain fatty acids (e.g., lactic, acetic, and formic acids), which osmotically increase intraluminal water content, soften stool, and stimulate peristalsis. In hepatic encephalopathy, the acidic environment reduces intestinal ammonia production and absorption by promoting conversion of NH3 to NH4+.
Polyethylene glycol 3350 (PEG 3350) is an osmotic laxative that works by retaining water in the stool through hydrogen bonding, increasing fecal water content and promoting bowel movements.
10-45 mL orally once daily, adjusted to produce 2-3 soft stools per day. Maximum 60 mL/day.
17 g (1 heaping tablespoon) dissolved in 4–8 oz of water, juice, soda, coffee, or tea, administered orally once daily. Maximum duration of use: 7 days.
None Documented
None Documented
Not applicable; lactulose is a non-absorbable disaccharide that exerts a local osmotic effect in the colon without systemic absorption. Systemic half-life is not relevant as it does not enter circulation.
Not applicable; polyethylene glycol 3350 is minimally absorbed and systemic half-life is not clinically relevant.
Primarily fecal (≥90%) as unchanged drug via colonic excretion; renal elimination is negligible (<1%).
Primarily excreted unchanged in feces (>90% of oral dose); negligible renal elimination (<0.1% recovered in urine).
Category C
Category C
Osmotic Laxative
Osmotic Laxative